Preparing your results

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Vascular tumors in livers with targeted inactivation of the von Hippel-Lindau tumor suppressor.

http://www.ncbi.nlm.nih.gov/pubmed/11171994

von Hippel-Lindau (VHL) disease is a pleomorphic familial tumor syndrome that is characterized by the development of highly vascularized tumors. Homozygous disruption of the VHL gene in mice results in embryonic lethality. To investigate VHL function in the adult we have generated a conditional VHL null allele (2-lox allele) and null allele (1-lox allele) by Cre-mediated recombination in embryonic stem cells. We show here that mice heterozygous for the 1-lox allele develop cavernous hemangiomas of the liver, a rare manifestation of the human disease. Histologically these tumors were associated with hepatocellular steatosis and focal proliferations of small vessels. To study the cellular origin of these lesions we inactivated VHL tissue-specifically in hepatocytes. Deletion of VHL in the liver resulted in severe steatosis, many blood-filled vascular cavities, and foci of increased vascularization within the hepatic parenchyma. These histopathological changes were similar to those seen in livers from mice heterozygous for the 1-lox allele. Hypoxia-inducible mRNAs encoding vascular endothelial growth factor, glucose transporter 1, and erythropoietin were up-regulated. We thus provide evidence that targeted inactivation of mouse VHL can model clinical features of the human disease and underline the importance of the VHL gene product in the regulation of hypoxia-responsive genes in vivo.

Pubmed ID: 11171994 RIS Download

Mesh terms: Albumins | Alleles | Animals | Erythropoietin | Genes, Tumor Suppressor | Hemangioma | Heterozygote | Ligases | Liver Neoplasms | Mice | Mice, Inbred BALB C | Mice, Knockout | Mice, Mutant Strains | Phenotype | Polycythemia | Proteins | Tumor Suppressor Proteins | Ubiquitin-Protein Ligases | Vascular Neoplasms | Von Hippel-Lindau Tumor Suppressor Protein

Research resources used in this publication

None found

Research tools detected in this publication

None found

Data used in this publication

None found

Associated grants

  • Agency: NCI NIH HHS, Id: 5-R35-CA44339
  • Agency: NIDDK NIH HHS, Id: K08 DK002668
  • Agency: NIDDK NIH HHS, Id: K08 DK002668-05
  • Agency: NIDDK NIH HHS, Id: K08-DK02668

Mouse Genome Informatics (Data, Gene Annotation)

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.